Exsilio Therapeutics

Exsilio Therapeutics is a manufacturer of genomic medicines aimed at transforming the treatment of a wide range of diseases. The company’s developed drugs can be delivered through lipid nanoparticles, providing lasting and safe treatment for various diseases, including genetic disorders, cancer, and autoimmune diseases, enabling enterprises to offer technologies based on naturally occurring genetic elements that can precisely insert new genes into cells via RNA intermediates.